I-Mab Biopharma Posts GAAP EPS -$0.48 I-Mab reported GAAP EPS of -$0.48 on Apr 7, 2026 (Seeking Alpha); institutional investors should prioritize cash-runway and filing-level disclosures within days.

I-Mab Biopharma Posts GAAP EPS -$0.48: I-Mab reported GAAP EPS of -$0.48 on Apr 7, 2026 (Seeking Alpha); institutional investors should prioritize cash-runway and filing-level disclosures within days. 👈 Read full analysis #Biotech #Investment #Finance #EarningsReport #IConomy